Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

All patients with venous thromboembolism (VTE) should receive anticoagulant treatment in
the absence of absolute contraindications. Initial anticoagulant treatment is crucial for …

These guidelines update the previous EANM 2009 guidelines on the diagnosis of
pulmonary embolism (PE). Relevant new aspects are related to (a) quantification of PE and …

The clinical management of patients with acute pulmonary embolism is rapidly changing
over the years. The widening spectrum of clinical management strategies for these patients …

Persons aged≥ 65 years not only account for over 60% of venous thromboembolism (VTE)
events, they have also a higher mortality and VTE-related morbidity than younger patients …

Older adults have a significantly greater risk of venous thromboembolism (VTE), including
deep vein thrombosis and pulmonary embolism, than younger adults. The cause of this …

Introduction The clinical significance of subsegmental pulmonary embolism (SSPE) is
currently unclear. Although growing evidence from observational studies suggests that …

Background Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity
and mortality worldwide. Common in COPD are acute exacerbations (AE-COPD) that cause …

Haemodynamic instability and right ventricular dysfunction are the key determinants of short-
term prognosis in patients with acute pulmonary embolism (PE). Residual thrombi and …

Introduction: Cancer associated thrombosis (CAT) is a frequent complication among cancer
patients. It is associated with increased morbidity, mortality, and psychological burden …